Industry News
ES Cell International teams up with PPL
Melbourne-based stem cell researcher ES Cell International has confirmed it is in talks with Scottish group PPL Therapeutics over the purchase of complementary research. [ + ]
Bristol-Myers warns high inventories to hit profit
Bristol-Myers Squibb, the top maker of cancer drugs, said on Monday that US wholesale inventories of its medicines are too high and reducing them will hurt future earnings. [ + ]
Science and innovation parliamentary committee
Science is set to feature in a new parliamentary committee, announced recently by the government.
[ + ]Victorian science heads north
Victorian scientists at the forefront of world stem cell research are planning to move part of their operation to New South Wales because research on spare IVF embryos is banned in Victoria.
[ + ]Biomedical research centre at USQ
The University of Southern Queensland's efforts in biomedical research are set to enhance the University's national and international standing, according to Dr Mike Kotiw, director of the centre for biomedical research.
[ + ]We don't want a stoush over board: Amrad
Amrad Corporation's embattled board has urged major shareholder Circadian Technologies against holding a general meeting in May, calling instead for internal discussions. [ + ]
Progen, Griffith team up in heparanase project
Queensland private sector and academic researchers will share an Australian Research Council grant to probe an enyzme that plays a role in cancer and inflammatory diseases. [ + ]
VC urges more pharma biotech commitment
The time is ripe to insist multinational pharmaceuticals lift their commitment to the local life sciences industry, claims venture capitalist Dr Geoff Brooke. [ + ]
New cell research centre to open for business
Creating artificial organs to help ease the transplantation demand gap is the ultimate aim of Australia's new centre for cell engineering. [ + ]
Austin director joins Prima board
Immunologist Prof Mark Hogarth has been appointed to the board of Melbourne biotech Prima Biomed. [ + ]
GroPep looks to sell off neuropathy research
GroPep is hoping to license out its research into a topical treatment for diabetic neuropathy after product development studies failed to come up with a suitable transdermal formulation. [ + ]
Biologist takes up attorney role
A molecular geneticist has joined Freehills Carter Smith Beadle's biotechnology group as a patent attorney. [ + ]
Trounson applauds Bracks' stem cell support
Victorian Premier Steve Bracks was courageous for supporting the use of spare IVF embryos for stem cell research, leading researcher Prof Alan Trounson said. [ + ]
NZ will not miss biotech opportunities
New Zealand may have opportunities on information and communications technology, but Pete Hodgson, NZ Science Minister, says he is determined not to let it happen again with biotechnology.
[ + ]Biomedical research fellowship program
The Western Australia Biomedical Research Institute (WABRI) has launched a A$500,000 fellowship program, funded jointly by Murdoch University, Curtin University of Technology, and Macquarie Bank Foundation.
[ + ]
